×
For best experience we recommend to activate Javascript in your browser.
TSC22D1 antibody (AA 803-1070)
This Rabbit Polyclonal antibody specifically detects TSC22D1 in WB, IHC, IP and ICC. It exhibits reactivity toward Human.
Quick Overview for TSC22D1 antibody (AA 803-1070) (ABIN7628749)
Target
See all TSC22D1 Antibodies
TSC22D1
(TSC22 Domain Family, Member 1 (TSC22D1))
Reactivity
All reactivities for TSC22D1 antibodies
Human
Host
All hosts for TSC22D1 antibodies
Rabbit
Clonality
All clonalities for TSC22D1 antibodies
Polyclonal
Conjugate
All conjugates for TSC22D1 antibodies
This TSC22D1 antibody is un-conjugated
Application
All applications for TSC22D1 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Product Details anti-TSC22D1 Antibody
(hide)
Binding Specificity
All epitopes for TSC22D1 antibodies
AA 803-1070
Purpose
Transforming Growth Factor Beta Stimulated Protein Clone 22 (TSC22) Polyclonal Antibody
Sequence
Pro803~Gly1070
Characteristics
The Transforming Growth Factor Beta Stimulated Protein Clone 22 (TSC22) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for TSC22D1
(hide)
Target
TSC22D1
(TSC22 Domain Family, Member 1 (TSC22D1))
Alternative Name
TSC22
Gene ID
8848
UniProt
Q15714
Recently viewed
(hide)
Chat with us , powered by LiveChat